Intention to receive COVID-19 vaccine during pregnancy: A systematic review and meta-analysis

Abstract Objective This meta-analysis aimed to assess the level of intent to receive coronavirus disease 2019 (COVID-19) vaccination and demographical factors influencing vaccine uptake among pregnant individuals. Study Design PubMed, Scopus, and archive/pre-print servers were searched up to May 22nd, 2021. Cross sectional surveys reporting the percentage of the pregnant individuals intending to get a COVID-19 vaccine were considered eligible for meta-analysis. This review was registered with PROSPERO (CRD42021254484). The primary outcome was to estimate the prevalence of COVID-19 vaccination intent among pregnant population. The secondary outcome was to evaluate the factors influencing the intention for vaccination. Results Twelve studies sourcing data of 16,926 individuals who were identified as pregnant were eligible. The estimated intention for the receipt of COVID-19 vaccine among women who were pregnant was 47% (95% CI: 38–57%), with the lowest prevalence in Africa 19% (95% CI: 17–21%) and the highest in Oceania 48.0% (95% CI: 44.0–51.0%). Uptake of other vaccines (influenza and/or TdaP) during pregnancy was associated with higher rate of intent to receive the COVID-19 vaccine (OR = 3.03; 95% CI: 1.37–6.73; p = 0.006). Conclusion The intent to receive COVID-19 vaccine is relatively low among women who are pregnant and substantially varies based on the country of residence. In our meta-analysis, intent of women who were pregnant to receive the COVID-19 vaccine was significantly associated with the history of receiving influenza or TdaP vaccine during pregnancy. Given that in every country only a minority of gravidae have received the COVID-19 vaccine, despite known risks of maternal morbidity and mortality with no evidence of risks of vaccination, it highlights the importance of revised approaches at shared decision making and focused public health messaging by national and international advisories. Key Points The estimated global intention for COVID-19 vaccination among pregnant women was 47%. The lowest intention was in Africa and the highest in Oceania. These findings highlight the importance of public health messaging by by different agencies.

[1]  B. Kampmann,et al.  Women’s views on accepting COVID-19 vaccination during and after pregnancy, and for their babies: a multi-methods study in the UK , 2021, BMC Pregnancy and Childbirth.

[2]  M. Eogan,et al.  “This choice does not just affect me.” Attitudes of pregnant women toward COVID-19 vaccines: a mixed-methods study , 2021, Human vaccines & immunotherapeutics.

[3]  L. Riley,et al.  Acceptance of COVID-19 vaccination in pregnancy: a survey study , 2021, American Journal of Obstetrics & Gynecology MFM.

[4]  N. Han,et al.  Acceptance of a COVID-19 vaccine and associated factors among pregnant women in China: a multi-center cross-sectional study based on health belief model , 2021, Human vaccines & immunotherapeutics.

[5]  Dilek Şahin,et al.  COVID‐19 vaccine acceptance in pregnant women , 2021, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[6]  G. Rizzo,et al.  Women perception of SARS-CoV-2 vaccination during pregnancy and subsequent maternal anxiety: a prospective observational study , 2021, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[7]  A. Khalil,et al.  Uptake of vaccination in pregnancy , 2021, Best Practice & Research Clinical Obstetrics & Gynaecology.

[8]  M. Stockwell,et al.  Attitudes Toward COVID-19 Illness and COVID-19 Vaccination among Pregnant Women: A Cross-Sectional Multicenter Study during August–December 2020 , 2021, American Journal of Perinatology.

[9]  V. Foulon,et al.  Vaccine Willingness and Impact of the COVID-19 Pandemic on Women’s Perinatal Experiences and Practices—A Multinational, Cross-Sectional Study Covering the First Wave of the Pandemic , 2021, International journal of environmental research and public health.

[10]  G. Rizzo,et al.  Pregnant women perspectives on SARS-COV-2 vaccine Condensation: Most of Italian pregnant women would not agree to get the SARS-COV-2 vaccine, irrespective of having features of high risk themselves, or being high-risk pregnancies. , 2021, American Journal of Obstetrics & Gynecology MFM.

[11]  H. V. Van Spall.  Exclusion of pregnant and lactating women from COVID-19 vaccine trials: a missed opportunity , 2021, European heart journal.

[12]  R. Rubin.  Pregnant People's Paradox-Excluded From Vaccine Trials Despite Having a Higher Risk of COVID-19 Complications. , 2021, JAMA.

[13]  C. Spong,et al.  COVID-19 Vaccination in Pregnant and Lactating Women. , 2021, JAMA.

[14]  S. Hernández-Díaz,et al.  COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries , 2021, European Journal of Epidemiology.

[15]  F. Chervenak,et al.  Professionally responsible coronavirus disease 2019 vaccination counseling of obstetrical and gynecologic patients , 2021, American Journal of Obstetrics and Gynecology.

[16]  G. Hal,et al.  Knowledge, Attitudes, and Practices towards COVID-19 of Pregnant Women at a Primary Health Care Facility in South Africa , 2021 .

[17]  M. Daly,et al.  International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples , 2020, Vaccine.

[18]  D. Goffman,et al.  COVID-19 Vaccine Acceptance Among Pregnant, Breastfeeding and Non-pregnant Reproductive Aged Women , 2021 .

[19]  A. Steptoe,et al.  Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications , 2020, The Lancet Regional Health - Europe.

[20]  M. Daly,et al.  Willingness to vaccinate against COVID-19 in the US: Longitudinal evidence from a nationally representative sample of adults from April–October 2020 , 2020, medRxiv.

[21]  E. Olsen,et al.  Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[22]  Gynecologists,et al.  Immunization for Pregnant Women: A Call to Action. , 2020, Nursing for women's health.

[23]  S. Crawford,et al.  Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults , 2020, Annals of Internal Medicine.

[24]  S. Lees,et al.  Protection by Exclusion: Another Missed Opportunity to Include Pregnant Women in Research During the Coronavirus Disease 2019 (COVID-19) Pandemic. , 2020, Obstetrics and gynecology.

[25]  S. Madhi,et al.  Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement , 2020, Frontiers in Immunology.

[26]  R. Farrell,et al.  Pregnant Women in Trials of Covid‐19: A Critical Time to Consider Ethical Frameworks of Inclusion in Clinical Trials , 2020, Ethics & human research.

[27]  K. Aagaard,et al.  Maternal death due to COVID-19 , 2020, American Journal of Obstetrics and Gynecology.

[28]  A. Khalil,et al.  Determinants of Influenza and Pertussis Vaccination Uptake in Pregnancy: A Multicenter Questionnaire Study of Pregnant Women and Healthcare Professionals. , 2019, The Pediatric infectious disease journal.

[29]  Mandy A. Allison,et al.  Obstetrician-Gynecologists' Strategies to Address Vaccine Refusal Among Pregnant Women. , 2019, Obstetrics and gynecology.

[30]  D. Schwartz.  Clinical Trials and Administration of Zika Virus Vaccine in Pregnant Women: Lessons (that Should Have Been) Learned from Excluding Immunization with the Ebola Vaccine during Pregnancy and Lactation , 2018, Vaccines.

[31]  Denise V. D’Angelo,et al.  Influenza and Tdap Vaccination Coverage Among Pregnant Women — United States, April 2018 , 2018, MMWR. Morbidity and mortality weekly report.

[32]  J. Hellwig.  Tdap Vaccination During Pregnancy , 2017 .

[33]  A. Dempsey,et al.  Influenza and Pertussis Vaccination Among Pregnant Women and Their Infants’ Close Contacts: Reported Practices and Attitudes , 2015, The Pediatric infectious disease journal.

[34]  F. Chervenak,et al.  Ethics in obstetrics and gynecology. An overview. , 1997, European journal of obstetrics, gynecology, and reproductive biology.

[35]  Acog Technical Bulletin.  Ethical decision-making in obstetrics and gynecology. , 1989, ACOG technical bulletin.